Prediction of Significant Prostate Cancer in Biopsy-Naïve Men: Validation of a Novel Risk Model Combining MRI and Clinical Parameters and Comparison to an ERSPC Risk Calculator and PI-RADS

PLoS ONE - United States
doi 10.1371/journal.pone.0221350
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Pd08-04 Validation of a Risk Calculator Predicting Biopsy Outcome in Prostate Cancer Treated With Active Surveillance

Journal of Urology
Urology
2016English

A Multiparametric Magnetic Resonance Imaging-Based Risk Model to Determine the Risk of Significant Prostate Cancer Prior to Biopsy

BJU International
Urology
2017English

Avoiding Biopsy in Men With PI-RADS Scores 1 and 2 on Multiparametric MRI of the Prostate, Ready for Prime Time?

BJU International
Urology
2019English

MRI-Guided Robotic Prostate Biopsy: A Clinical Accuracy Validation

Lecture Notes in Computer Science
Computer ScienceTheoretical Computer Science
2010English

Novel Immune–risk Score of Gastric Cancer: A Molecular Prediction Model Combining the Value of Immune–risk Status and Chemosensitivity

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

MRI Assisted Stereotactic Biopsy (MAST) in Patients With Elevated Prostate Cancer Risk and Previous Negative Biopsy

JOJ Urology & Nephrology
2017English

Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers

Radiology
Nuclear MedicineRadiologyImaging
2016English

Head-To-Head Comparison of Prostate Cancer Risk Calculators Predicting Biopsy Outcome

Translational Andrology and Urology
Reproductive MedicineUrology
2018English

Pi-Lba03 Testosterone Therapy and Prostate Cancer Risk

Journal of Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy